- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 15, 2025 | 6.48M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $4.18M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $4.34M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $3.59M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $2.77M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $2.66M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $3.31M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $5.91M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $5.47M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $6.53M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $6.41M |
| Capex | Q1 2025 · Mar 31, 2024 | $2.07K |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$638.21K |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $1.13M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$1.34M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $163.3K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $122.81K |